Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease

Overview of attention for article published in Frontiers in Neuroscience, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 1 policy source
twitter: 12 X users

facebook: 1 Facebook page

Readers on

mendeley: 69 Mendeley

Summary Policy documents X Facebook

So far, Altmetric has seen 1 policy document that references this research output.

Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition

Cited by Canadian Agency for Drugs and Technologies in Health on 20 Sep 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.